Boston Scientific Operating Expense Breakdown

History

Date	Selling, General, and Administrative	Research and Development	Amortization	Restructuring Net Charges	Royalty Expense	Asset and Goodwill Impairment	Litigation-related Net Charges	Loss on Disposal of Assets	Contingent Consideration Net Expense
Sep 30, 2024	5.75B	1.52B	840.00M	31.00M	36.00M	-	-	-	10.00M
Jun 30, 2024	5.43B	1.47B	843.00M	38.00M	42.00M	277.00M	-	-	45.00M
Mar 31, 2024	5.34B	1.44B	840.00M	53.00M	45.00M	-	-	-	62.00M
Dec 31, 2023	5.19B	1.42B	829.00M	70.00M	46.00M	-	-	-	57.00M
Sep 30, 2023	4.97B	1.38B	820.00M	57.00M	47.00M	58.00M	20.00M	-	10.00M
Jun 30, 2023	4.86B	1.37B	814.00M	46.00M	47.00M	182.00M	-	-	18.00M
Mar 31, 2023	4.68B	1.34B	808.00M	41.00M	46.00M	-	-	-	35.00M
Dec 31, 2022	4.52B	1.32B	803.00M	25.00M	47.00M	-	173.00M	22.00M	35.00M
Sep 30, 2022	4.51B	1.31B	796.00M	42.00M	45.00M	329.00M	-	-	50.00M
Jun 30, 2022	4.44B	1.28B	778.00M	47.00M	48.00M	332.00M	170.00M	-	4.00M
Mar 31, 2022	4.40B	1.25B	754.00M	39.00M	49.00M	-	-	-	-117.00M
Dec 31, 2021	4.36B	1.20B	741.00M	40.00M	49.00M	370.00M	430.00M	18.00M	-135.00M
Sep 30, 2021	4.23B	1.17B	743.00M	53.00M	52.00M	312.00M	-	48.00M	-115.00M
Jun 30, 2021	4.15B	1.18B	756.00M	74.00M	50.00M	403.00M	580.00M	8.00M	-83.00M
Mar 31, 2021	3.83B	1.12B	773.00M	74.00M	46.00M	-	282.00M	6.00M	2.00M
Dec 31, 2020	3.79B	1.14B	789.00M	79.00M	46.00M	590.00M	278.00M	-	-100.00M
Sep 30, 2020	3.85B	1.17B	796.00M	71.00M	49.00M	451.00M	483.00M	-	-128.00M

Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.